Dr. Giuseppe Curigliano is the head of the Division of Early Drug Development at the European Institute of Oncology and an Associate Professor of Medical Oncology at the University of Milano in Italy. He is the founding member and scientific chair for the International Cardio-Oncology Society (ICOS) and has received the first ESO Umberto Veronesi Award in Vienna in 2017 and the Fellowship of the European Academy of Cancer Sciences in Paris in 2017.
Read moreDr. X is the Director of the Radiation Oncology Unit and holds a Degree in Medicine and Surgery from the School of Medicine of Università La Sapienza, Rome, Italy. He specializes in the application of high-tech radiation oncology treatments such as Intensity Modulated Radiation Therapy, Stereotactic Radiation Therapy, Adaptive Radiation Therapy, and Brachitherapy. He has a particular focus on optimizing radiation treatments for Upper Gastro-intestinal, Prostate, and Lung cancers. He also is an Assistant Professor in Radiation Oncology for the Medical School, Radiation Oncology Resident Program, and Diagnostic and Therapy Radiography University Degree at Università Cattolica del Sacro Cuore, Rome, Italy and a Faculty Member of the ESTRO Teaching Course “Evidence Based Radiation Oncology”.
Read moreDirector of the General Surgery Unit at Mater Olbia Hospital with Medical Degree with Honors from Catholic University, Rome, Italy and Certificate of Specialist in General Surgery. Experienced in performing over 1300 surgical procedures including liver, pancreas, and kidney transplants and 500 cases of oncologic operations. Teaching activity at School of Medicine and Surgery, Cattolica International, Università Cattolica del Sacro Cuore, Rome, Italy. Member of Italian Society of Surgery and the Italian Society of Oncologic Surgery. Author and co-author of publications in international journals.
Read more